Cyclic hydroxamic acids as metalloproteinase inhibitors
US6429213B1 · kind B1 · utility
51Cited by
1References
42Claims
0Family size
Inventors
Key dates
| Filing date | Jun 17, 1999 |
| Grant date | Aug 6, 2002 |
| Priority date | — |
| Expiry date | Jun 17, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application de gibes novel cyclic hydroxamic acids of formula I: or pharmaceutically acceptable salt forms thereof, wherein ring B is a 5-7 membered cyclic system containing from 0-2 heteroatoms selected from O, N, NRa, and S(O)p, and 0-1 carbonyl groups and the other variables are defined in the present specification, which are useful as metalloprotease inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.